期刊文献+

严重脓毒症抗凝治疗的新认识 被引量:12

原文传递
导出
摘要 严重脓毒症(severe sepsis)是指在感染因素导致全身炎症反应综合征基础上合并脏器功能障碍、组织灌注不足或低血压。早期过度炎性介质的释放是脓毒症发病中至关重要的环节。近20年来,人们治疗严重脓毒症的重点主要针对体内失控性炎症反应,包括使用糖皮质激素、内毒素中和抗体、各种致炎细胞因子的特异性抑制剂等,但是大规模、多中心临床试验均未证实上述措施能显著改善严重脓毒症患者的预后。近年来,人们进一步认识到脓毒症的病理生理学基础是全身性炎症反应、凝血/纤溶系统障碍和免疫功能紊乱等诸因素相互影响、相互作用的结果。
出处 《中华儿科杂志》 CAS CSCD 北大核心 2006年第8期569-572,共4页 Chinese Journal of Pediatrics
  • 相关文献

参考文献10

  • 1Bernard GR,Vincent JL,Laterre PF,et al.Efficacy and safety of recombinant human activated protein C for severe sepsis.N Engl J Med,2001,344:699-709.
  • 2Fourrier F.Recombinant human activated protein C in the treatment of severe sepsis:an evidence-based review.Crit Care Med,2004,32 (11 Suppl):534-541.
  • 3Dellinger RP,Carlet JM,Masur H,et al.Surviving sepsis campaign guidelines for management of severe sepsis and septic shock.Intensive Care Med,2004,30:536-555.
  • 4Aird WC.Sepsis and coagulation.Crit Care Clin,2005,21:417-431.
  • 5Warren BL,Eid A,Singer P,et al.Caring for the critically ill patients.High-dose antithrombin Ⅲ in severe sepsis:a randomized controlled trial.JAMA,2001,286:1869-1878.
  • 6Abraham E,Reinhart K,Opal S,et al.Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis:a randomized controlled trial.JAMA,2003,290:238-247.
  • 7van der Wouwer M,Collen D,Conway EM.Thrombomodulin-protein C-EPCR system:integrated to regulate coagulation and inflammation.Arteriscler Thromb Vasc Biol,2004,24:1374-1383.
  • 8姚咏明,盛志勇.重视对脓毒症本质的探讨[J].中华急诊医学杂志,2005,14(3):185-186. 被引量:118
  • 9O'Brien LA,Gupta A,Grinnell BW.Activated protein C and sepsis.Front Biosci,2006,11:676-698.
  • 10Parker MM,Hazelzet JA,Carcillo JA.Pediatric considerations.Crit Care Med,2004,32:S591-S594.

二级参考文献6

  • 1Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med, 2003, 348(2):138-150.
  • 2Efron PA, Tinsley K, Minnich DJ,et al. Increased lymphoid tissue apoptosis in baboons with bacteremic shock. Shock, 2004, 21(6):566-571.
  • 3Dellinger RP, Carlet JM, Masur H,et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med, 2004, 32(7):858-873.
  • 4Bernard GR, Vincent JL, Laterre PF,et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med, 2001, 344(10):699-709.
  • 5Tracey KJ. The inflammatory reflex. Nature, 2002, 420(6917): 853-859.
  • 6盛志勇,姚咏明.脓毒症与多器官功能障碍综合征[J].中华急诊医学杂志,2003,12(10):653-654. 被引量:78

共引文献117

同被引文献155

引证文献12

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部